title: Author's reply to: "Prognostic value of cetuximab related skintoxicity in metastatic colorectal cancer patients and its correlation with parameters of the EGFR signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group".
authors.forename: Sebastian
authors.initials: S
authors.lastname: Stintzing
authors.forename: Volker
authors.initials: V
authors.lastname: Heinemann
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D066246:ErbB Receptors / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D012867:Skin / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D066246:ErbB Receptors